10.08.2020Will novel pharmaceutical approaches target epigenetic networks?

In this review, Ambrosini et al. delineate the main epigenetic networks underlying cardiometabolic afflictions and shed light on potential therapeutic targets of pharmacological reprogramming. For details, check out the full article.